Evidence map›Paper›PMID 41141165›Full record

ArticleCureus2025

Griscelli Syndrome Type 2 Revealed by Macrophage Activation Syndrome: Two Cases From the Same Family.

Boutayna Halimy, Abdelilah Radi, Azzeddine Laaraje, Hassani Amale, Rachid Abilkassem

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Boutayna HalimyPediatric Department, Mohammed V Military Training Hospital, Mohammed V University, Rabat, MAR.
Abdelilah RadiPediatric Department, Mohammed V Military Training Hospital, Mohammed V University, Rabat, MAR.
Azzeddine LaarajePediatric Department, Mohammed V Military Training Hospital, Mohammed V University, Rabat, MAR.
Hassani AmalePediatric Department, Mohammed V Military Training Hospital, Mohammed V University, Rabat, MAR.
Rachid AbilkassemPediatric Department, Mohammed V Military Training Hospital, Mohammed V University, Rabat, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Griscelli syndrome type 2 is a rare autosomal recessive disorder caused by mutations in the RAB27A gene. It is characterized by partial albinism, a silvery sheen of the hair, and an immune deficiency. We report cases of two siblings, a seven-year-old boy and his 10-year-old sister, who were admitted to the emergency department with sepsis complicated by macrophage activation syndrome. Their clinical course was rapidly unfavorable. The diagnosis of Griscelli syndrome type 2 was made in the light of a combination of clinical and biological arguments: oculocutaneous hypopigmentation, silvery sheen of the hair, the absence of psychomotor delay, the occurrence of a macrophage activation syndrome following an infection, and especially the pathognomonic appearance on microscopic examination of a hair sample. The absence of giant granulations in the nucleated cells made it possible to eliminate Chediak-Higashi syndrome. Griscelli syndrome type 2 should be considered in children presenting with hypopigmentation, silvery hair, and immune dysregulation, particularly when complicated by macrophage activation syndrome.

Indexed as

griscelli syndromehereditary diseaseimmune deficiencymacrophage activation syndromepartial albinism

Identifiers

PMID41141165
PMCPMC12553321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.